The purpose of this study is to obtain conjunctiva and tenon's capsule thickness measurements in vivo using spectral domain-optical coherence tomography (SD-OCT) in participants with nAMD/DME and age-matched healthy subjects.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Cohorts A and B: Conjunctival Thickness Measured Using SD-OCT
Timeframe: At study visit (Day 1)
Cohorts A and B: Tenon's Capsule Thickness Measured Using SD-OCT
Timeframe: At study visit (Day 1)
Cohorts A and B: Sum of Conjunctival and Tenon's Capsule Measured Using SD-OCT
Timeframe: At study visit (Day 1)
Cohorts A and B: Number of Participants in Age Groups 45-54, 55-64, 65-74, ≥75 Years
Timeframe: At study visit (Day 1)